Latest & greatest articles for pulmonary embolism

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pulmonary embolism or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pulmonary embolism and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pulmonary embolism

21. Society of Interventional Radiology Position Statement on Catheter-Directed Therapy for Acute Pulmonary Embolism

Society of Interventional Radiology Position Statement on Catheter-Directed Therapy for Acute Pulmonary Embolism Journal of Vascular and Interventional Radiology Email/Username: Password: Remember me Available now: Use your SIR login to access JVIR. Search Terms Search within Search Share this page Copyright © 2018 Inc. All rights reserved. | | | | | | The content on this site is intended for health professionals. We use cookies to help provide and enhance our service and tailor content and ads

Society of Interventional Radiology2018

22. A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism

A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism 29631073 2018 05 14 1879-2472 165 2018 05 Thrombosis research Thromb. Res. A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism. 107-111 S0049-3848(18)30300-1 10.1016/j.thromres.2018.04.002 The Bova score has shown usefulness in the identification of intermediate-high risk patients with acute pulmonary embolism (PE), but lacks prospective validation (...) . The aim of this study was to prospectively validate the Bova score in different settings from the original derivation cohort. Consecutive, normotensive patients with acute PE recruited at 13 academic or general hospitals were stratified, using their baseline data, into the three Bova risk stages (I-III). The primary outcome was the 30-day composite of PE-related mortality, hemodynamic collapse and non-fatal PE recurrences in the three risk categories. In the study period, 639 patients were enrolled

EvidenceUpdates2018

23. Sex-specific performance of pre-imaging diagnostic algorithms for pulmonary embolism

Sex-specific performance of pre-imaging diagnostic algorithms for pulmonary embolism 29460484 2018 05 02 1538-7836 16 5 2018 May Journal of thrombosis and haemostasis : JTH J. Thromb. Haemost. Sex-specific performance of pre-imaging diagnostic algorithms for pulmonary embolism. 858-865 10.1111/jth.13984 Essentials Decision rules for pulmonary embolism are used indiscriminately despite possible sex-differences. Various pre-imaging diagnostic algorithms have been investigated in several (...) prospective studies. When analysed at an individual patient data level the algorithms perform similarly in both sexes. Estrogen use and male sex were associated with a higher prevalence in suspected pulmonary embolism. Background In patients suspected of pulmonary embolism (PE), clinical decision rules are combined with D-dimer testing to rule out PE, avoiding the need for imaging in those at low risk. Despite sex differences in several aspects of the disease, including its diagnosis, these algorithms

EvidenceUpdates2018

24. Assessment of coexisting deep vein thrombosis for risk stratification of acute pulmonary embolism

Assessment of coexisting deep vein thrombosis for risk stratification of acute pulmonary embolism 29476988 2018 04 24 1879-2472 164 2018 04 Thrombosis research Thromb. Res. Assessment of coexisting deep vein thrombosis for risk stratification of acute pulmonary embolism. 40-44 S0049-3848(18)30212-3 10.1016/j.thromres.2018.02.140 In patients with acute pulmonary embolism (PE), studies have shown an association between coexisting deep vein thrombosis (DVT) and short-term prognosis (...) . It is not known whether complete compression ultrasound testing (CCUS) improves the risk stratification of their disease beyond the recommended prognostic models. We included patients with normotensive acute symptomatic PE and prognosticated them with the European Society of Cardiology (ESC) risk model for PE. Subsequently, we determined the prognostic significance of coexisting DVT in patients with various ESC risk categories. The primary endpoint was a complicated course after the diagnosis of PE, defined

EvidenceUpdates2018

25. Acute Pulmonary Embolism in a National Danish Cohort: Increasing Incidence and Decreasing Mortality

Acute Pulmonary Embolism in a National Danish Cohort: Increasing Incidence and Decreasing Mortality 29536465 2018 03 14 2567-689X 118 3 2018 Mar Thrombosis and haemostasis Thromb. Haemost. Acute Pulmonary Embolism in a National Danish Cohort: Increasing Incidence and Decreasing Mortality. 539-546 10.1160/TH17-08-0531 This study reports the incidence, clinical profile and mortality for acute pulmonary embolism (PE) patients in the Danish population in four eras from 2004 to 2014. Patients (...) admitted with first-time acute PE from 2004 through 2014 were identified from national patient registries classified according to the International Classification of Diseases, 10th edition, World Health Organization. A total of 30,275 patients from a population of 4,301,673 adult residents aged 18 years or older were diagnosed with first-time acute PE, corresponding to an incidence of 64 (95% confidence interval: 61-66) per 100,000 adult residents per year. Throughout the study period, PE incidence

EvidenceUpdates2018

26. Rapid blood test helps exclude pulmonary embolism for low risk patients

Rapid blood test helps exclude pulmonary embolism for low risk patients NIHR DC | Signal - Rapid blood test helps exclude pulmonary embolism for low risk patients Dissemination Centre Discover Portal NIHR DC Discover NIHR Signal Rapid blood test helps exclude pulmonary embolism for low risk patients Published on 25 October 2016 An inexpensive blood test can help quickly rule out pulmonary embolism for low risk patients attending hospital outpatient or emergency departments, especially in people (...) ’s. People who test positive will still need diagnostic imaging. Overall a change in the management pathway for suspected pulmonary embolism (PE) have potential to be cost saving and provide better care. Commissioners, will be interested in the overall pathway costs but unfortunately these were not researched here. Why was this study needed? In the UK, 47,734 cases of PE were reported between 2014 and 2015. Emergency admissions for PE increased by 30% between 2008 and 2012. A pulmonary embolism

NIHR Dissemination Centre2018

27. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism

Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism V Venous thromboembolism in o enous thromboembolism in ov ver 16s: er 16s: reducing the risk of hospital-acquired reducing the risk of hospital-acquired deep v deep vein thrombosis or pulmonary ein thrombosis or pulmonary embolism embolism NICE guideline Published: 21 March 2018 nice.org.uk/guidance/ng89 © NICE 2018. All rights reserved. Subject to Notice of rights (https (...) in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism (NG89) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 41Contents Contents Overview 5 Who is it for? 5 Recommendations 6 1.1 Risk assessment 6 1.2 Giving information and planning for discharge 8 1.3 All patients 10 1.4 Interventions for people with acute coronary syndromes or acute stroke or for acutely ill patients 12

National Institute for Health and Clinical Excellence - Clinical Guidelines2018

28. Combination of Pulmonary Embolism Rule-out Criteria and YEARS Algorithm in a European Cohort of Patients with Suspected Pulmonary Embolism

Combination of Pulmonary Embolism Rule-out Criteria and YEARS Algorithm in a European Cohort of Patients with Suspected Pulmonary Embolism 29390226 2018 03 13 2567-689X 118 3 2018 Mar Thrombosis and haemostasis Thromb. Haemost. Combination of Pulmonary Embolism Rule-out Criteria and YEARS Algorithm in a European Cohort of Patients with Suspected Pulmonary Embolism. 547-552 10.1055/s-0038-1623535 Both the YEARS algorithm and the pulmonary embolism (PE) rule-out criteria (PERC) were created (...) to exclude PE with limited diagnostic tests. A diagnostic strategy combining both scores might save additional computed tomography pulmonary angiography (CTPA) scans, but they have never been evaluated in conjunction. The aim of this study was to determine the safety and efficiency of combining YEARS and PERC in a single diagnostic strategy for suspected PE. The PERC rule was assessed in 1,316 consecutive patients with suspected PE who were managed according to YEARS. We calculated the absolute

EvidenceUpdates2018

30. Effect of the Pulmonary Embolism Rule-Out Criteria on Subsequent Thromboembolic Events Among Low-Risk Emergency Department Patients: The PROPER Randomized Clinical Trial.

Effect of the Pulmonary Embolism Rule-Out Criteria on Subsequent Thromboembolic Events Among Low-Risk Emergency Department Patients: The PROPER Randomized Clinical Trial. Importance: The safety of the pulmonary embolism rule-out criteria (PERC), an 8-item block of clinical criteria aimed at ruling out pulmonary embolism (PE), has not been assessed in a randomized clinical trial. Objective: To prospectively validate the safety of a PERC-based strategy to rule out PE. Design, Setting (...) , and Patients: A crossover cluster-randomized clinical noninferiority trial in 14 emergency departments in France. Patients with a low gestalt clinical probability of PE were included from August 2015 to September 2016, and followed up until December 2016. Interventions: Each center was randomized for the sequence of intervention periods. In the PERC period, the diagnosis of PE was excluded with no further testing if all 8 items of the PERC rule were negative. Main Outcomes and Measures: The primary end

JAMA2018 Full Text: Link to full Text with Trip Pro

31. Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta-analysis

Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta-analysis 29215781 2018 02 12 1538-7836 16 2 2018 Feb Journal of thrombosis and haemostasis : JTH J. Thromb. Haemost. Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta-analysis. 279-292 10.1111/jth.13921 Essentials Clinical prediction rules (CPRs) can stratify patients with pulmonary embolism (PE (...) ) and cancer. A meta-analysis was done to assess prognostic accuracy in CPRs for mortality in these patients. Eight studies evaluating ten CPRs were included in this study. CPRs should continue to be used with other patient factors for mortality risk stratification. Background Cancer treatment is commonly complicated by pulmonary embolism (PE), which remains a leading cause of morbidity and mortality in these patients. Some guidelines recommend the use of clinical prediction rules (CPRs) to help

EvidenceUpdates2018

32. Treating pulmonary embolism at home?

Treating pulmonary embolism at home? Treating pulmonary embolism at home? Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics Treating pulmonary embolism at home? View/ Open Date 2012-06 Format Metadata Abstract Treat low-risk patients with pulmonary embolism (PE) with low-molecular-weight heparin (LMWH) in an outpatient

PURLS2018

33. Pulmonary embolism

Pulmonary embolism Pulmonary embolism - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Pulmonary embolism Last reviewed: August 2018 Last updated: July 2018 Summary Pulmonary embolism (PE) is a life-threatening condition resulting from dislodged thrombi occluding the pulmonary vasculature; right heart failure and cardiac arrest may ensue if not aggressively treated. Symptoms include chest pain, dyspnoea, and a sense (...) of apprehension. Haemoptysis and syncope are less common; the latter is strongly associated with increased clot burden. Clinical probability, assessed by a validated prediction rule and/or clinical judgement, is the basis for all diagnostic strategies for PE. Computed tomographic pulmonary angiography is the definitive diagnostic modality. However, a negative ventilation-perfusion lung scan effectively excludes PE. Haemodynamically unstable patients require urgent primary re-perfusion, anticoagulation

BMJ Best Practice2018

34. Clinical Value of Ultrasonography in Diagnosis of Pulmonary Embolism in Critically Ill Patients

Clinical Value of Ultrasonography in Diagnosis of Pulmonary Embolism in Critically Ill Patients JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE / OCT-DEC 2017 / VOL 5 | ISSUE 4 200 Address for Correspondence: Dr. Xiao-chun Ma, Department of Critical Care Medicine, the First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning Province, China. Email: xcma2972@sina.com Access this article online Website: www.intern-med.com DOI: 10.1515/jtim-2017-0034 Quick Response Code: Review (...) Article ABSTRACT Pulmonary embolism (PE) is a clinical emergency that will increase the mortality if complicated with unstable hemodynamics. Because of its nonspecific clinical symptoms, it’s a great challenge to make a PE diagnosis. The golden standard to diagnose PE is computed tomography of pulmonary artery (CTPA), but a diagnosis of PE also composed of evaluation of PE risk factors, possibilities, and risk stratification. Ultrasonography may detect right ventricle strain related to hemodynamic

Journal of translational internal medicine2017 Full Text: Link to full Text with Trip Pro

35. No added value of the age-adjusted D-dimer cut-off to the YEARS algorithm in patients with suspected pulmonary embolism

No added value of the age-adjusted D-dimer cut-off to the YEARS algorithm in patients with suspected pulmonary embolism 28941051 2017 12 05 1538-7836 15 12 2017 Dec Journal of thrombosis and haemostasis : JTH J. Thromb. Haemost. No added value of the age-adjusted D-dimer cut-off to the YEARS algorithm in patients with suspected pulmonary embolism. 2317-2324 10.1111/jth.13852 Essentials Imaging is warranted in the majority of patients to confirm or rule out pulmonary embolism (PE). The age (...) -adjusted D-dimer (ADJUST) reduced the number of required imaging tests in patients ≥ 50 years. The YEARS algorithm was designed to improve the efficiency in patients with suspected PE. There was no added value of implementing ADJUST in the YEARS algorithm in our cohort. Background The YEARS algorithm was designed to simplify the diagnostic work-up of pulmonary embolism (PE) and to reduce the number of necessary computed tomography pulmonary angiography (CTPA) scans. An alternative strategy to reduce

EvidenceUpdates2017

37. Approaches to Diagnosing Acute Pulmonary Embolism in Canada: current practice, challenges, and availability of testing

Approaches to Diagnosing Acute Pulmonary Embolism in Canada: current practice, challenges, and availability of testing Approaches to Diagnosing Acute Pulmonary Embolism in Canada: current practice, challenges, and availability of testing | CADTH.ca Find the information you need Approaches to Diagnosing Acute Pulmonary Embolism in Canada: current practice, challenges, and availability of testing Approaches to Diagnosing Acute Pulmonary Embolism in Canada: current practice, challenges (...) , and availability of testing Published on: November 8, 2016 Project Number: ES0307-000 Product Line: Result type: Report CADTH is undertaking an environmental scan to identify and summarize information regarding pulmonary embolism (PE) imaging in Canada. The scan will describe current practice, challenges, and enablers in diagnosing PE, and the availability of tests, scans, and tools for diagnosing PE. The key objectives of this environmental scan are as follows: Identify current practice related to diagnostic

Canadian Agency for Drugs and Technologies in Health - Environmental Scanning2017

38. Assessing clinical probability of pulmonary embolism: prospective validation of the simplified Geneva score

Assessing clinical probability of pulmonary embolism: prospective validation of the simplified Geneva score 28688113 2017 07 08 2017 09 05 1538-7836 15 9 2017 Sep Journal of thrombosis and haemostasis : JTH J. Thromb. Haemost. Assessing clinical probability of pulmonary embolism: prospective validation of the simplified Geneva score. 1764-1769 10.1111/jth.13770 Essentials The simplified Geneva score allows easier pretest probability assessment of pulmonary embolism (PE). We prospectively (...) validated this score in the ADJUST-PE management outcome study. The study shows that it is safe to manage patients with suspected PE according to this score. The simplified Geneva score is now ready for use in routine clinical practice. Background Pretest probability assessment by a clinical prediction rule (CPR) is an important step in the management of patients with suspected pulmonary embolism (PE). A limitation to the use of CPRs is that their constitutive variables and corresponding number

EvidenceUpdates2017

39. Pulmonary embolism prognostic factors and length of hospital stay: A cohort study

Pulmonary embolism prognostic factors and length of hospital stay: A cohort study 28646727 2017 06 24 2017 07 25 1879-2472 156 2017 Aug Thrombosis research Thromb. Res. Pulmonary embolism prognostic factors and length of hospital stay: A cohort study. 155-159 S0049-3848(17)30373-0 10.1016/j.thromres.2017.06.009 Patients with pulmonary embolism (PE) are commonly admitted to hospital for their initial treatment. We aimed to assess the association of length of hospital stay with commonly available (...) clinical variables and their combinations. A retrospective multicenter cohort study was conducted on consecutive PE patients admitted to eight Italian centers. Logistic regression analysis was performed to evaluate the association between the length of hospital stay and the Pulmonary Embolism Severity Index (PESI) parameters, National Early Warning Score (NEWS) and other possible determinants. We enrolled 391 patients, with a median hospital stay of 10days (IQR 7-14). Among PESI parameters, only oxygen

EvidenceUpdates2017

40. Lixiana (edoxaban) - for the prevention of embolism in patients with nonvalvular atrial fibrillation OR treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE.

Lixiana (edoxaban) - for the prevention of embolism in patients with nonvalvular atrial fibrillation OR treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE. Lixiana (edoxaban) × Insert searchphrase to search the website Insert searchphrase to search the website > > > Lixiana (edoxaban) Conclusion Lixiana (edoxaban) is the fourth Non-vitamin K Oral Anticoagulant (NOAC) in Denmark after Eliques (apixaban), Xarelto (rivaroxaban) and Pradaxa (...) (dabigatran). Lixiana is indicated for the prevention of embolism in patients with nonvalvular atrial fibrillation (NVAF) with one or more risk factors and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE. For either indication, Lixiana is not inferior to warfarin when it comes to preventing embolism and has a statistically significantly lower occurrence of major bleeding. The lower risk of bleeding is particularly evident in comparisons

Danish Pharmacotherapy Reviews2017